2020
DOI: 10.1136/archdischild-2020-319391
|View full text |Cite
|
Sign up to set email alerts
|

Acute asthma management considerations in children and adolescents during the COVID-19 pandemic

Abstract: Viewpoint purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…The main therapy goal for patients with asthma with or without COVID-19 is minimizing exacerbations and achieving asthma control (38). There are significant risks to a child suffering from a severe asthma attack and these attacks can result in fatal outcomes (34). Therefore, any deviation from planned, individualized asthma therapy, including nebulization, should be avoided wherever possible.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The main therapy goal for patients with asthma with or without COVID-19 is minimizing exacerbations and achieving asthma control (38). There are significant risks to a child suffering from a severe asthma attack and these attacks can result in fatal outcomes (34). Therefore, any deviation from planned, individualized asthma therapy, including nebulization, should be avoided wherever possible.…”
Section: Discussionmentioning
confidence: 99%
“…In those patients with evident improvement following acute treatment in a healthcare setting, nebulization may have to be performed in home settings as a continuation of the acute treatment (33). Withholding nebulization therapy may also lead to respiratory failure in severe cases (34). There are concerns regarding the overabundance of caution that HCPs and health institutions might exercise in their approach to the use of nebulizers that may lead to unfavourable patient outcomes (35).…”
Section: Duplicate Articles N=2mentioning
confidence: 99%
“…2,3 There is wide agreement that management of asthma exacerbation with or without COVID-19 should continue as before with increased frequency of SABA therapy delivered through metered-dose inhaler using a spacer, particularly during the first hour of presentation to the emergency department. 10 We are, in our view, fortunate that both numerous and intense attacks on SABA have not been successful. To phase out SABA, as emphatically called for by these authors, would in our opinion, be a critical error.…”
Section: Commentarymentioning
confidence: 94%
“…There is wide agreement that management of asthma exacerbation with or without COVID-19 should continue as before with increased frequency of SABA therapy delivered through metered-dose inhaler using a spacer, particularly during the first hour of presentation to the emergency department. 10 …”
Section: Commentarymentioning
confidence: 99%